The latest price target for CareTrust REIT (NYSE:CTRE) was reported by Keybanc on October 7, 2024. The analyst firm set a price target for $34.00 expecting CTRE to rise to within 12 months (a possible 12.32% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for CareTrust REIT (NYSE:CTRE) was provided by Keybanc, and CareTrust REIT maintained their overweight rating.

The last upgrade for CareTrust REIT Inc happened on October 1, 2024 when Wells Fargo raised their price target to $34. Wells Fargo previously had an equal-weight for CareTrust REIT Inc.

The last downgrade for CareTrust REIT Inc happened on April 18, 2022 when Barclays changed their price target from $22 to $17 for CareTrust REIT Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareTrust REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareTrust REIT was filed on October 7, 2024 so you should expect the next rating to be made available sometime around October 7, 2025.

While ratings are subjective and will change, the latest CareTrust REIT (CTRE) rating was a maintained with a price target of $27.00 to $34.00. The current price CareTrust REIT (CTRE) is trading at is $30.27, which is within the analyst’s predicted range.